SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 16.27 |
Enterprise Value ($M) | n/a |
Book Value ($M) | 17.20 |
Book Value / Share | 1.05 |
Price / Book | n/a |
NCAV ($M) | 9.63 |
NCAV / Share | 0.59 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.33 |
Return on Assets (ROA) | -0.72 |
Return on Equity (ROE) | -1.21 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.93 |
Current Ratio | 1.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 32.39 |
Assets | 39.96 |
Liabilities | 22.76 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | 683 Capital Management, LLC | 6.10 | -86.99 | |
13G/A | Ridgeback Capital Investments L.P. | 9.90 | 15.34 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
39,974 | 108,559 | 36.82 | |
30,990 | 96,503 | 32.11 | |
25,915 | 130,836 | 19.81 | |
30,784 | 149,744 | 20.56 | |
(click for more detail) |
Similar Companies | |
---|---|
ACIU – AC Immune SA | ACRV – Acrivon Therapeutics, Inc. |
ADMA – ADMA Biologics, Inc. | ALT – Altimmune, Inc. |
ANIP – ANI Pharmaceuticals, Inc. |